| P2093 | author name string | Marie Scully | |
| | Alastair G Proudfoot | |
| | Matthew D Kelham | |
| | Rosalba Spiritoso | |
| | Liam Gleeson | |
| | Inma Alcalde | |
| P2860 | cites work | Eculizumab in severe Shiga-toxin-associated HUS | Q28238525 |
| | Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life support. | Q33360730 |
| | Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry | Q33404151 |
| | A case series of the successful use of ECMO, continuous renal replacement therapy, and plasma exchange for thrombocytopenia-associated multiple organ failure | Q33407927 |
| | Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement | Q33423769 |
| | Direct cardiac involvement in childhood hemolytic-uremic syndrome: case report and review of the literature | Q33435533 |
| | HUS and atypical HUS. | Q33441069 |
| | Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry. | Q37684248 |
| | Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score | Q41701343 |
| | HUS-induced cardiac and circulatory failure is reversible using cardiopulmonary bypass as rescue. | Q48285884 |
| P433 | issue | 2 | |
| P304 | page(s) | 191-193 | |
| P577 | publication date | 2019-03-07 | |
| P1476 | title | Extra-corporeal membrane oxygenation and Eculizumab: Atypical treatments for typical haemolytic uraemic syndrome | |
| P478 | volume | 21 | |